Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

124.46 USD -0.76 (-0.61%)
Streaming Delayed Price Updated: 10:24 AM EDT, May 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 619,117
Open 124.39
Bid (Size) 124.45 (3)
Ask (Size) 124.47 (1)
Prev. Close 125.22
Today's Range 124.05 - 124.90
52wk Range 87.68 - 132.30
Shares Outstanding N/A
Dividend Yield 1.86%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Medtronic Receives “World Changing Idea” Recognition
Tags Pharma News, Research & Solutions Healthcare Industry News Company Ratings
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Medtronic Launches New Pediatric Monitor That Alerts Clinicians To Potential Airway Obstructions During Ventilation
SonarMed™ Airway Monitoring System Continuously Checks for Endotracheal Tube Obstruction and Position for Neonates and Infants Providing Immediate, Actionable Intelligence for Clinicians 
From PR Newswire

Performance

YTD
+7.27%
+7.27%
1 Month
+2.19%
+2.19%
3 Month
+5.58%
+5.58%
6 Month
+8.64%
+8.64%
1 Year
+26.05%
+26.05%

More News

Read More
Health Crisis Leads to Surge in Medical Technology Innovation
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Health Crisis Leads to Surge in Medical Technology Innovation
From PR Newswire
Advanced Sensor Technology Enables a Modernized Approach to Healthcare
From PR Newswire
Medtronic Announces CareGuidePro™, a New Mobile App and Online Platform for Patients to Navigate Their Spinal Cord Stimulation Journey
From PR Newswire
Medtronic Announces CE Mark of Evolut™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
From PR Newswire
Procedure-Related Techniques and Care Pathways from the OPTIMIZE PRO Clinical Study Show Promising Early Outcomes for Patients Implanted with the Medtronic Evolut™ TAVR System
From PR Newswire
Medtronic Receives FDA Breakthrough Designation for the Emprint™ Ablation Catheter Kit
From PR Newswire
Medtronic Receives FDA Approval to Launch Clinical Study for Implantable Tibial Neuromodulation Therapy for Bladder Incontinence
From PR Newswire
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.